CN107440090A - 一种复合医用食品及其制备方法 - Google Patents
一种复合医用食品及其制备方法 Download PDFInfo
- Publication number
- CN107440090A CN107440090A CN201610397963.9A CN201610397963A CN107440090A CN 107440090 A CN107440090 A CN 107440090A CN 201610397963 A CN201610397963 A CN 201610397963A CN 107440090 A CN107440090 A CN 107440090A
- Authority
- CN
- China
- Prior art keywords
- glycine betaine
- modified starch
- medical food
- water
- composite medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 61
- 239000002131 composite material Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 116
- 229960003237 betaine Drugs 0.000 claims abstract description 99
- 229920000881 Modified starch Polymers 0.000 claims abstract description 76
- 239000004368 Modified starch Substances 0.000 claims abstract description 76
- 235000019426 modified starch Nutrition 0.000 claims abstract description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 64
- 235000005911 diet Nutrition 0.000 claims abstract description 52
- 230000000378 dietary effect Effects 0.000 claims abstract description 51
- 239000012736 aqueous medium Substances 0.000 claims abstract description 24
- RUECTJATXCACED-UHFFFAOYSA-N 2-aminoacetic acid;hydrate Chemical compound [OH-].[NH3+]CC(O)=O RUECTJATXCACED-UHFFFAOYSA-N 0.000 claims abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000013049 sediment Substances 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 239000000287 crude extract Substances 0.000 claims description 8
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 6
- 241000335053 Beta vulgaris Species 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 235000011194 food seasoning agent Nutrition 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000013517 stratification Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 21
- 238000010008 shearing Methods 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 230000009969 flowable effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 238000010348 incorporation Methods 0.000 abstract description 2
- 239000012567 medical material Substances 0.000 abstract description 2
- 230000001537 neural effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 21
- 238000009472 formulation Methods 0.000 description 18
- 239000011259 mixed solution Substances 0.000 description 14
- 238000013019 agitation Methods 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000002574 poison Substances 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002389 environmental scanning electron microscopy Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- NJZRLXNBGZBREL-UHFFFAOYSA-N glycine betaine hydrate Chemical group [OH-].C[N+](C)(C)CC(O)=O NJZRLXNBGZBREL-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000012620 biological material Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical group C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610397963.9A CN107440090B (zh) | 2016-06-07 | 2016-06-07 | 一种复合医用食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610397963.9A CN107440090B (zh) | 2016-06-07 | 2016-06-07 | 一种复合医用食品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107440090A true CN107440090A (zh) | 2017-12-08 |
CN107440090B CN107440090B (zh) | 2020-09-08 |
Family
ID=60486034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610397963.9A Active CN107440090B (zh) | 2016-06-07 | 2016-06-07 | 一种复合医用食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107440090B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102665441A (zh) * | 2009-12-22 | 2012-09-12 | Fmc有限公司 | 用于食品应用的水分散性组合物 |
CN104125779A (zh) * | 2011-12-15 | 2014-10-29 | 雀巢产品技术援助有限公司 | 在吞咽困难患者中促进安全吞咽的粘性稀薄液体 |
CN105473003A (zh) * | 2013-03-28 | 2016-04-06 | 费森尤斯卡比德国有限公司 | 用于吞咽困难患者的营养的组合物 |
-
2016
- 2016-06-07 CN CN201610397963.9A patent/CN107440090B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102665441A (zh) * | 2009-12-22 | 2012-09-12 | Fmc有限公司 | 用于食品应用的水分散性组合物 |
CN104125779A (zh) * | 2011-12-15 | 2014-10-29 | 雀巢产品技术援助有限公司 | 在吞咽困难患者中促进安全吞咽的粘性稀薄液体 |
CN105473003A (zh) * | 2013-03-28 | 2016-04-06 | 费森尤斯卡比德国有限公司 | 用于吞咽困难患者的营养的组合物 |
Non-Patent Citations (1)
Title |
---|
李德海 等: "玉米直链淀粉的制备及其特性", 《食品科学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN107440090B (zh) | 2020-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1985846B (zh) | 褐藻多糖硫酸酯在制备治疗心脑血管疾病的药物中的用途 | |
CN105496981B (zh) | 一种壳寡糖片剂及其制备方法 | |
US20120321704A1 (en) | Compound sea Cucumber Product, Preparation Method, and Dosage Forms Thereof | |
CN108245496A (zh) | 虾青素抗炎增效组合 | |
CN104498180B (zh) | 一种从南极磷虾油中提取高纯度磷脂的方法 | |
CN103110889A (zh) | 一种有助于增强免疫力的中药及其制备方法 | |
WO2008028410A1 (fr) | Utilisation de fucoïdane de faible masse moléculaire dans la préparation d'un médicament destiné au traitement de maladies cardio-vasculaires et cérébrovasculaires | |
CN104107424A (zh) | 治疗心脑血管疾病的养气溶栓药物组合物及其制备方法 | |
CN106880839A (zh) | 一种鹿骨片及其制备方法 | |
CN102766220A (zh) | 一种疏水改性β-1,3-D-葡聚糖及其制备方法与应用 | |
CN107440090A (zh) | 一种复合医用食品及其制备方法 | |
CN104473169B (zh) | 一种含鱼胶的保健品及其制备方法 | |
CN103932184B (zh) | 一种中药组合物 | |
CN104605227A (zh) | 一种具有保健功能的空心胶囊 | |
CN1389475A (zh) | 一种枸杞多糖及其制备方法和应用 | |
JP2001181303A (ja) | フコイダン様多糖複合体及びその製造方法並びにそれを主成分とする免疫賦活剤 | |
CN109223721A (zh) | 磷脂水飞蓟维生素e组合物及其制备方法和应用 | |
JP2001316402A (ja) | 金耳由来の低分子量酸性ヘテロ多糖を含有する加水分解物、これを有効成分とする薬剤及びこれを含有する飲食品 | |
CN101991665B (zh) | 治疗扩张型心肌病、股骨头坏死和肿瘤的组合物及其制备工艺 | |
Kereh et al. | The Digestive Tract of Lohman Chicken | |
CN105614888A (zh) | 一种亲水性可食用营养材料包覆姜黄素改善其水溶性的制备方法 | |
CN113694168B (zh) | 一种降压降脂中药制剂及其制备方法 | |
CN103876085A (zh) | 一种锁阳枸杞调料及其制造方法 | |
CN107573432A (zh) | 一种具有抗炎效果的牛樟芝寡糖及其制备方法和用途 | |
CN104082552A (zh) | 一种可增强免疫力的兔饲料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220706 Address after: Room 201-10, building 17, Dongyi District, No. 105, West Third Ring North Road, Haidian District, Beijing 100089 Patentee after: Beijing Weihang Jiye Investment Consulting Co.,Ltd. Address before: 100080 No. 2 North First Street, Haidian District, Beijing, Zhongguancun Patentee before: INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES Patentee before: The first hospital of Peking University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220829 Address after: 518057 L502, China Resources Building, No. 2666, Keyuan South Road, Haizhu Community, Yuehai Street, Nanshan District, Shenzhen, Guangdong, China Patentee after: Shenzhen Weihang Yining Biotechnology Co.,Ltd. Address before: Room 201-10, building 17, Dongyi District, No. 105, West Third Ring North Road, Haidian District, Beijing 100089 Patentee before: Beijing Weihang Jiye Investment Consulting Co.,Ltd. |
|
TR01 | Transfer of patent right |